Rethinking evidence: a multidisciplinary approach to the use of synthetic data in healthcare - part I

Authors

  • Alessandro Brusadelli
  • Davide Ruffo
  • Chiara di Somma
  • Alexander Boudewijn

DOI:

https://doi.org/10.15168/2284-4503-3747

Keywords:

Synthetic data, clinical trials, Health Technology Assessment (HTA), artificial intelligence, data protection

Abstract

This essay explores the role of synthetic data in clinical trials and Health Technology Assessment, highlighting its transformative potential on epistemological and legal levels. Adopting a multidisciplinary approach, it examines the compatibility of such data with European health law and the evidence-based design paradigm. The aim is to propose a systemic interpretation of the current legal framework that legitimizes synthesization as an emerging form of evidence generation, calling for the development of a new legal grammar capable of reconciling technological innovation, fundamental rights, and the sustainability of healthcare systems.

Published

2025-10-23

How to Cite

1.
Brusadelli A, Ruffo D, di Somma C, Boudewijn A. Rethinking evidence: a multidisciplinary approach to the use of synthetic data in healthcare - part I. BioLaw [Internet]. 2025 Oct. 23 [cited 2026 Jan. 25];(3):317-41. Available from: https://teseo.unitn.it/biolaw/article/view/3747

Issue

Section

Artifical Intelligence and Law - Essays

Most read articles by the same author(s)